Find and Pitch Jounalists, Get Your Story Covered

Tags: TechnipFMC Petrobras iEPCI Department Stores department-stores

	Profile	Recent Articles on Subject
1	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab Is New Standard of Care for High-Risk Early-Stage TNBC - 4 days ago FDA Breakthrough Therapy Designation Granted to Novel Psychedelic Molecule CYB003 for Major Depressive Disorder - 6 months ago Phase 3 Study Supports Pembrolizumab Plus Lenvatinib as Standard of Care in Patients With Advanced Endometrial Cancer Who Received Prior Platinum Therapy - 11 months ago
2	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Bristol immunotherapy improves responses in lung cancer, setting up Phase 3 study - 6 days ago STAT+: Viking Therapeutics to move its oral obesity drug into Phase 2 study after early success - 6 months ago STAT+: Mixed study results for MorphoSys blood-cancer drug raise questions about approval - 10 months ago
3	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Grants Orphan Drug Designation to AISA-021 for Systemic Sclerosis - 8 days ago FDA Grants Orphan Drug, Fast Track Designation to RLS-0071 for aGVHD - about 1 month ago FDA Grants Orphan Drug Designation to PT217 for Neuroendocrine Carcinoma - about 1 month ago AstraZeneca to Initiate Trial for Triple-Combination Inhaled Therapy for Chronic Obstructive Pulmonary Disease - 6 months ago Samsung Bioepis Initiates Phase 1 Trial for Proposed Keytruda Biosimilar - 7 months ago FDA Grants Breakthrough Therapy Designation to Epcoritamab for Follicular Lymphoma - 10 months ago AB-1002 Demonstrates Improvements for Congestive Heart Failure in First-in-Human Study - 10 months ago FDA Grants Breakthrough Therapy Designation to Novel Drug for Progressive Pulmonary Fibrosis - 11 months ago Phase 3 Trials of Survodutide for Overweight, Obesity to Begin Recruiting Patients - 11 months ago Early-Phase Cancer Trials Show More Diversity in 2022 Compared to 2000 - 12 months ago
4	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Phase 2 PREDICT-ILD imaging study commences in interstitial lung disease - 10 days ago Boehringer Ingelheim’s survodutide shows promise in liver fibrosis treatment - 3 months ago
5	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	GSK5764227 Receives Breakthrough Therapy Designation to Treat Extensive-Stage Small–Cell Lung Cancer - about 1 month ago FDA Grants Priority Review for Durvalumab to Treat Small Cell Lung Cancer - about 1 month ago FDA Grants Rare Pediatric Disease Designation to SAT-3247 to Treat Duchenne Muscular Dystrophy - about 1 month ago FDA Grants Fast Track Designation for LYT-200 to Treat Head and Neck Cancers - 5 months ago FDA Grants Orphan Drug Designation for CAN-2409 to Treat Pancreatic Cancer - 5 months ago Jazz Pharmaceuticals Submits Biologics License Application for Zanidatamab to Treat Biliary Tract Cancer - 6 months ago Phase 3 Trial of Pembrolizumab with Olaparib Did Not Meet Endpoints Among Individuals with NSCLC - 6 months ago Phase 3 EVOKE-01 Study in Metastatic NSCLC Falls Short of Primary Endpoint - 7 months ago Researchers Announce Positive Trial Data for the Use of Remibrutinib In Chronic Spontaneous Urticaria - 10 months ago
6	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about Zepbound trial results, an Alnylam heart drug, and more - about 1 month ago STAT+: Pharmalittle: We’re reading about a liver-drug approval, pharma’s positive outlook, and more - 6 months ago
7	Kristen Monaco MedPage Today	Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - about 2 months ago JAK Inhibitor Preserves Beta-Cell Function in Early Type 1 Diabetes - 10 months ago Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D - 10 months ago
8	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Novel TKI Promising in Early Study of HER2-Mutant NSCLC - 3 months ago
9	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Perioperative Tislelizumab Demonstrates Survival Benefit in NSCLC - 7 months ago Novel Drug Makes Its Case for Pretreated Primary Biliary Cholangitis - 10 months ago
10	Damian Garde STAT News Biotech reporter at STAT. Open to messages. biotechnologyjournalism	Alnylam thickened the plot - 7 months ago

Journalists covering Phase 1b/2 Trial